! Read Iran COVID-19 epidemic models situation report No 32 - 2021-12-17 [here](https://github.com/pourmalek/covir2/blob/main/situation%20reports/32%20Iran%20COVID-19%20epidemic%20models%20situation%20report%20No%2032%20–%202021-12-17.pdf)

### Study update dates in uptake 20211217

**_DELP 20211216_**, IHME 20211119, **_IMPE 20211205_**, **_SRIV 20211217_**

IMPE update 20211205 released on 20211215. 

<br/><br/>

***********************************************************************************************************************************************************
***********************************************************************************************************************************************************

## The Omicron variant not yet in the models as of 2021-12-17:

None of the models have included the Omicron variant as of 2021-12-17.

The IHME model has not included the Omicron variant as of their 2021-11-19 update (latest update available on 2021-12-17). Sources: "COVID-19 estimate downloads" (https://www.healthdata.org/covid/data-downloads). "This page was last updated at 12:00 p.m. Pacific, November 19, 2021. IHME is working to incorporate new data surrounding the Omicron variant into its projections. Our team is monitoring the growing concerns, and we are working to provide new models that reflect the latest developments. We will update the forecasts as soon as we’ve factored Omicron into the scenarios."



The Imperial model has not included the Omicron variant as of their 2021-12-05 update (latest update available on 2021-12-17). Sources: "COMBINED Situation Report for COVID-19 2021-12-05" (https://github.com/mrc-ide/global-lmic-reports/blob/master/combined_reports.pdf) "This report adjusts for
the Delta variant, with the variant become dominant over the period: 2021-09-13 to 2021-11-12."


The DELPHI model (https://covidanalytics.io/projections) and the SRIV model (https://scc-usc.github.io/ReCOVER-COVID-19/) do not mention inclusion of alpha. 

<br/><br/>

***********************************************************************************************************************************************************
***********************************************************************************************************************************************************

## The Omicron variant, Farshad Pourmalek's take, 2021-12-15:

## Given all available evidence so far, Omicron will most probably leave more cases, hospitalizations, and even deaths compared to previous waves, due to exponential growth – even with counterfactual scenarios of full lockdowns and highest coverages 3 doses of mRNA vaccines. Percent fatality and hospitalization lower than delta, but absolute numbers, higher. 

## Most politicians and half-politician-half-scientists repeat the same negligent mistakes with every new variant of concern. Refractory to treatment.

Farshad Pourmalek, December 15, 2021 

<br/><br/>

************************************************************************************************************************************************************
************************************************************************************************************************************************************



*

### Merged graphs of uptake 20211217 [here](https://github.com/pourmalek/covir2/blob/main/20211217/graphs%20merged%2020211217.pdf)

****

<br/><br/>


### Selected graphs

****

(1) Iran [Daily deaths, all time](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2011%20COVID-19%20daily%20deaths%2C%20Iran%2C%20reference%20scenarios%2C%20all%20time.pdf)


****

(1b) Iran [Reported daily deaths, peaks, post-peaks, and linear trends](https://github.com/pourmalek/covir2/blob/main/20211217/output/JOHN/graph%201%20COVID-19%20daily%20deaths%2C%20Iran%2C%20Johns%20Hopkins.pdf)


****

(2) Iran [Daily deaths, 2021](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2012%20COVID-19%20daily%20deaths%2C%20Iran%2C%20reference%20scenarios.pdf)


****

(3) Iran [Daily deaths, 2021, reference scenario with uncertainty, IHME](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2014%20COVID-19%20daily%20deaths%2C%20Iran%2C%20reference%20scenario%20with%20uncertainty%2C%20IHME.pdf)


****

(4) Iran [Daily deaths, 2021, 3 scenarios, IHME](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2015%20COVID-19%20daily%20deaths%2C%20Iran%2C%203%20scenarios%2C%20IHME.pdf)


****

(5) Iran [Daily deaths, 2021, reference scenario with uncertainty, IMPE](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2016%20COVID-19%20daily%20deaths%2C%20Iran%2C%20reference%20scenario%20with%20uncertainty%2C%20IMPE.pdf)


****

(6) Iran [Daily deaths, 2021, 3 scenarios, IMPE](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2017%20COVID-19%20daily%20deaths%2C%20Iran%2C%203%20scenarios%2C%20IMPE.pdf)


****

(7) Iran [Daily cases or infections, all time](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2021%20COVID-19%20daily%20cases%2C%20Iran%2C%20reference%20scenarios%2C%20all%20time.pdf)

    
****

(7b) Iran [Reported cases, peaks, post-peaks, and linear trends](https://github.com/pourmalek/covir2/blob/main/20211217/output/JOHN/graph%202%20COVID-19%20daily%20cases%2C%20Iran%2C%20Johns%20Hopkins.pdf)


****

(8) Iran [Daily cases or infections, 2021](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2022%20COVID-19%20daily%20cases%2C%20Iran%2C%20reference%20scenarios.pdf)

  
****

(8b) Iran [Daily cases, 2021](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2022b%20COVID-19%20daily%20cases%2C%20Iran%2C%20reference%20scenarios.pdf)


****

(8c) Iran [Daily estimated infections IHME IMPE to reported cases JOHN, main scenarios, 2021](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2029%20C19%20daily%20estimated%20infections%20to%20reported%20cases%2C%20Iran%2C%20reference%20scenarios%202021.pdf)


****

(9) Iran [Hospital-related outcomes, all time](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2071a%20COVID-19%20hospital-related%20outcomes%2C%20all%20time.pdf)


****

(10) Iran [Hospital-related outcomes, 2021](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2072%20COVID-19%20hospital-related%20outcomes%2C%20wo%20extremes%2C%202021.pdf)


****

(11) Iran [Daily deaths estimated to reported, all time](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2091%20COVID-19%20daily%20deaths%20estimated%20to%20reported%2C%20Iran%2C%20reference%20scenarios%2C%20all%20time.pdf)

  
****

(12) Iran [Daily cases or infections estimated to reported cases, 2021](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%2094%20COVID-19%20daily%20cases%20estimated%20to%20reported%2C%20Iran%2C%20reference%20scenarios.pdf) 

  
****
****

(13) Iran [R effective, 3 scenarios, IHME](https://github.com/pourmalek/covir2/blob/main/20211217/output/IHME/graph%2039%20COVID-19%20R%20effective%2C%20Iran%2C%203%20scenarios%2001jun2021%20on.pdf)


****

(14) Iran [Daily Infection-outcome ratios, 3 scenarios, IHME](https://github.com/pourmalek/covir2/blob/main/20211217/output/IHME/graph%2021g%20COVID-19%20daily%20Infection%20outcomes%20ratios%2C%20Iran%203%20scenarios%2C%20IHME.pdf)


****

(15) Iran [Daily mobility, 3 scenarios, IHME](https://github.com/pourmalek/covir2/blob/main/20211217/output/IHME/graph%2033%20COVID-19%20daily%20mobility%2C%20Iran%2C%203%20scenarios.pdf)


****

(16) Iran [Daily mask use, 3 scenarios, IHME](https://github.com/pourmalek/covir2/blob/main/20211217/output/IHME/graph%2034%20COVID-19%20daily%20mask_use%2C%20Iran%2C%203%20scenarios.pdf)


****

(17) Iran [Percent cumulative vaccinated, IHME](https://github.com/pourmalek/covir2/blob/main/20211217/output/merge/graph%20105%20COVID-19%20cumulative%20vaccinated%20percent%2C%20Iran%20IHME.pdf)


****



